Novel PET agent zeroes in on cancer stem cells

07/2/2014 | (free registration)

Research presented at the SNMMI Annual Meeting involving 16 human subjects with primary or metastatic brain lesions showed that the new PET tracer iodine-124 CLR1404 looks promising for detection of brain tumors by homing in on cancer stem cells. "Cancer stem cells are inherently resistant to radiotherapy and chemotherapy. If you leave behind as few as 100 cancer stem cells, patients often have [disease] progression and a more aggressive form of the disease," said researcher Dr. Lance Hall.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC